Comparing Semaglutide Administered Subcutaneously Once Daily to Semaglutide Administered Subcutaneously Once Weekly

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2015
This trial is conducted in Europe. The aim of this trial is to compare the steady-state exposure of semaglutide administered subcutaneously once daily to semaglutide administered subcutaneously once weekly in healthy subjects.
Epistemonikos ID: 5746ea1fd272137d3b1b64b5824a28c62d430edb
First added on: May 12, 2024